Docoh
Loading...

AEMD Aethlon Medical

News

From Benzinga Pro
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
28 Dec 21
Pre-Market Outlook, Markets, Movers
Watching Aethlon Medical Shares; Zacks Sets $8 Price Target
12 Nov 21
Price Target, Analyst Ratings
https://s27.q4cdn.com/906368049/files/News/2021/Zacks_SCR_Research_11122021_AEMD_Marin.pdf
AEMD: Strong balance sheet, expanded management team & new CRO relationship expected to facilitate clinical efforts
12 Nov 21
Penny Stocks
By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
10 Nov 21
Pre-Market Outlook, Markets, Movers
Aethlon Medical Q2 EPS $(0.13) Beats $(0.15) Estimate, Sales $131.97K Miss $190.00K Estimate
9 Nov 21
Earnings, News
Aethlon Medical (NASDAQ:AEMD) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 13.33 percent increase over losses of $(0.15) per share from
Aethlon Medical's Return On Capital Employed Insights
9 Nov 21
Earnings
According to data from Benzinga Pro, during Q1, Aethlon Medical's (NASDAQ:AEMD) reported sales totaled $131.97 thousand. Despite a 7.34% increase in earnings, the company posted a loss of $2.10 million.
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
9 Nov 21
Biotech, Earnings, News, Penny Stocks, Guidance, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours:
Earnings Scheduled For November 9, 2021
9 Nov 21
Earnings, M&A, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter. • KT (NYSE:KT) is projected to report earnings for its third quarter.